Thermo Fisher Scientific this week reported first-quarter revenue growth of three percent year-over-year, with revenues for its Analytical Technologies segment, which includes the company's life sciences mass spectrometry business, climbing 9 percent to $1.18 billion from $1.08 billion a year ago.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.